Chang K.-L.WUH-LIANG HWUYeh H.-Y.NI-CHUNG LEEYIN-HSIU CHIEN2020-12-092020-12-0920101079-9796https://www.scopus.com/inward/record.uri?eid=2-s2.0-72649102093&doi=10.1016%2fj.bcmd.2009.09.005&partnerID=40&md5=45d4ce96e8d0fbee9981a074e4cb0367https://scholars.lib.ntu.edu.tw/handle/123456789/525169[SDGs]SDG2[SDGs]SDG3CCL18 chemokine; chemokine; chitotriosidase; unclassified drug; chitotriosidase deficiency; controlled study; disease activity; disease marker; enzyme deficiency; enzyme linked immunosorbent assay; Gaucher disease; human; letter; major clinical study; Niemann Pick disease; priority journal; protein analysis; protein blood level; Biological Markers; Chemokines, CC; Gaucher Disease; Hexosaminidases; Humans; Niemann-Pick Disease, Type A; Niemann-Pick Disease, Type B; Splenectomy; Time Factorsletter10.1016/j.bcmd.2009.09.005198191712-s2.0-72649102093